Introduction
Ibutilide an anti-arrhythmic drug (Vaughn Wiliams Classification Type III) is used to support the cardioversion of atrial fibrillation and atrial flutter since some years yet. In some countries ibutilide is also used as an emergency treatment for the pharmacological cardioversion of new arised atrial flutter instead of electroversion. In this prospective study the effectiveness and safety of this emergency treatment were investigated.